Interact Coalition News
INTERACT COALITION MEMBERSHIP EXPANDS TO ADVANCE PATIENT ACCESS TO GENETIC TESTING FOR HEREDITARY CANCER RISK
SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- The Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), a coalition whose mission is to increase evidence-based access to genetic testing for people with or at risk of hereditary cancers, is happy to...
INTERACT Supports Updated NCCN Guidelines that Expand Access to Appropriate Hereditary Cancer Genetic Testing for Patients with Colorectal, Endometrial, and Gastric Cancers
SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- The Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT) applauds the National Comprehensive Cancer Network (NCCN) for recent updates to its Genetic/Familial High-Risk Assessment: Colorectal, Endometrial,...
INTERACT COALITION FORMED TO ADVANCE PATIENT ACCESS TO GENETIC TESTING FOR HEREDITARY CANCER RISK
SAN DIEGO, April 3, 2024 /PRNewswire/ -- Leading commercial organizations and patient advocacy groups in the field of cancer genetics today announced the founding of the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), a coalition whose...
Founding Members





